Cargando…
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
At present, there are no proven agents for treatment of coronavirus disease (COVID-19). The available evidence has not allowed guidelines to clearly recommend any drugs outside the context of clinical trials. The novel coronavirus SARS-CoV-2 that causes COVID-19 invokes a hyperinflammatory state dri...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292936/ https://www.ncbi.nlm.nih.gov/pubmed/32535732 http://dx.doi.org/10.1007/s40290-020-00342-z |